Peptide Dosages

cropped-pdlogo-nr

Peptide
Dosages

Menu

Livagen (20mg Vial) Dosage Protocol

Contents

Quickstart Highlights

Livagen is a synthetic tetrapeptide (Lys‑Glu‑Asp‑Ala) examined for chromatin remodeling and gene‑expression effects in aging cells. Cell and cytogenetic studies report activation of ribosomal genes and de‑condensation of heterochromatin in lymphocytes from older adults, and related work describes gene‑regulatory actions of short peptides broadly[1][5][6]. This page presents a once‑daily subcutaneous example with clear syringe math to keep injection volumes within typical SC tolerability ranges[7].

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration (unit‑friendly dilution for small‑volume SC injections)[7].
  • Example daily range (for syringe math): 500–2000 mcg once daily with gradual titration (no standardized human dosing established for Livagen; this is an educational example anchored to SC volume principles)[7].
  • Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe.
  • Storage: After reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F)[11]. Lyophilized vials are commonly kept frozen (e.g., around −20 °C (−4 °F)) within general freezer ranges used in healthcare[12].
Livagen (20mg Vial)
📘 Important: Before viewing any protocol, please consult our Prep & Injection Guide for essential preparation and safety instructions.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~6.67 mg/mL; 1 unit ≈ 66.7 mcg)

Week Daily Dose (mcg) Units (per injection) (mL)
Weeks 1–2 500 mcg 8 units (0.08 mL)
Weeks 3–4 1000 mcg 15 units (0.15 mL)
Weeks 5–6 1500 mcg 23 units (0.23 mL)
Weeks 7–12 2000 mcg 30 units (0.30 mL)

Route & frequency: Inject once daily subcutaneously. Example volumes above keep each administration ≤0.30 mL, within typical SC tolerability ranges described for drugs and biologics[7].

Low‑unit precision: For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

  1. Clean vial stopper and work area; allow alcohol to dry[9][10].
  2. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  3. Inject slowly down the vial wall; avoid foaming; gently swirl to dissolve (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F)[11].
Important: This guide is for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. For research use only.

Supplies Needed

Plan based on an 8–16 week once‑daily protocol with a gradual increase in dose.

  • Peptide Vials (Livagen, 20 mg each):
    • 8 weeks (titration to 2.0 mg/day): ≈ 4 vials (rounded)
    • 12 weeks: ≈ 7 vials (rounded)
    • 16 weeks: ≈ 10 vials (rounded)
  • Insulin Syringes (U‑100):
    • Per week: 7 syringes (1/day)
    • 8 weeks: 56 syringes
    • 12 weeks: 84 syringes
    • 16 weeks: 112 syringes
  • Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
    • 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
    • 12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
    • 16 weeks (10 vials): 30 mL → 3 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.
    • Per week: 14 swabs (2/day)
    • 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
    • 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
    • 16 weeks: 224 swabs → recommend 3 × 100‑count boxes
Peptide Vial
Insulin Syringes
Bacteriostatic Water
Alcohol Pads

Protocol Overview

Concise summary of a once‑daily regimen with unit‑friendly dilution.

  • Concept: Model small‑volume SC dosing while Livagen’s cellular actions are described in the literature as chromatin/gene‑expression modulation[1][5][6].
  • Schedule: Daily subcutaneous administrations for 8–12 weeks (extend to 16 weeks if desired).
  • Example Dose Range: 0.5–2.0 mg once daily with gradual titration (educational syringe‑math framework; agent‑specific human SC dosing standards are not established)[7].
  • Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for readable insulin‑syringe markings.
  • Storage: Reconstituted 2–8 °C (35.6–46.4 °F)[11]; lyophilized commonly frozen within routine freezer ranges[12].

Dosing Protocol

Suggested once‑daily titration to keep SC volumes small[7].

  • Start: 500–1000 mcg daily; increase by ~500 mcg every 1–2 weeks as tolerated.
  • Target: 1500–2000 mcg daily by Weeks 7–12.
  • Frequency: Once per day (subcutaneous).
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks.
  • Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F)[11].
  • Lyophilized: Store frozen around −20 °C (−4 °F) within common healthcare freezer ranges[12].
  • Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes; dispose in a sharps container[10].
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and lipohypertrophy[8][9].
  • Inject slowly; do not aspirate for subcutaneous injections[8].
  • Document daily dose and site rotation to maintain consistency.

How This Works

Livagen and related short peptides are reported to interact with chromatin and influence gene transcription programs in aging cells, including activation of ribosomal genes and selective remodeling of heterochromatin; broader reviews describe nuclear access and DNA‑associated interactions of short regulatory peptides[1][5][6]. Additional experimental work notes enzyme‑modulating effects (e.g., enkephalin‑degrading enzymes) and influences on digestive enzyme activity and hepatocyte protein‑synthesis rhythms in animal/cell models[2][3][4].

Potential Benefits & Side Effects

Summary of findings from preclinical and mechanistic literature.

  • Activation of ribosomal genes and de‑condensation of heterochromatin in lymphocytes from older adults[1][6].
  • Modulation of proteolytic enzymes (e.g., inhibition of enkephalin‑degrading enzymes in vitro)[4].
  • Influence on gastrointestinal enzyme activity and weak hydrolysis in the small intestine in rats; oral administration studies report enzyme activity changes varying by age[3].
  • General SC administration considerations: occasional mild injection‑site reactions; rotate sites and avoid aspiration per established guidance[8][9][10].

Injection Technique

General subcutaneous guidance from reputable clinical resources[7][8][9][10].

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue; do not aspirate[8].
  • Inject slowly and steadily; wait a few seconds before withdrawing the needle.
  • Rotate sites (abdomen, thighs, upper arms) to minimize local reactions and lipohypertrophy[9][10].

Recommended Source

We recommend Prime Lab Peptides for high‑purity Livagen (20 mg).

Why Prime Lab Peptides?

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

References


  • Khavinson VK, et al. (2002) Bulletin of Experimental Biology and Medicine
    — Effects of Livagen on chromatin activation in lymphocytes from older adults.
    View Source

  • Brodsky VY, et al. (2001) Izv Akad Nauk Ser Biol
    — Rhythm of protein synthesis in rat hepatocyte cultures; effect of Livagen.
    View Source

  • Timofeeva NM, et al. (2005) Bull Exp Biol Med
    — Effect of peptide Livagen on activity of digestive enzymes; oral administration in rats.
    View Source

  • Kost NV, et al. (2003) Biochemistry (Moscow)
    — Livagen and Epitalon inhibit enkephalin‑degrading enzymes; opioid receptor interactions.
    View Source

  • Khavinson VK, et al. (2021) Int J Mol Sci
    — Systematic review: Short peptides regulate gene expression and interact with chromatin.
    View Source

  • Lezhava T, et al. (2023) Georgian Med News
    — Epigenetic modification of “old” chromatin; selective effects of Livagen (KEDA) and related peptides in elderly lymphocytes.
    View Source

  • Berger M, et al. (2019) Adv Ther (PMC)
    — Subcutaneous drug injection: pharmacology and typical injection volumes.
    View Source

  • CDC
    — Vaccine administration: subcutaneous route (angle, site; no aspiration).
    View Source

  • CDC
    — Subcutaneous injection technique guide (PDF).
    View Source

  • NCBI Bookshelf (WHO)
    — Best practices for injection: asepsis, preparation, administration.
    View Source

  • USP <659> (2017)
    — Packaging and storage definitions: Refrigerator 2–8 °C (36–46 °F).
    View Source

  • CDC Pink Book — Chapter 5
    — Storage temperature ranges: refrigerators 2–8 °C; freezers −50 to −15 °C.
    View Source